ArticleMechanisms of ageing and development2021
A new mechanistic insight into fate decisions during yeast cell aging process.
Article in Mechanisms of ageing and development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transcriptional Reprogramming of Lifespan-Associated Genes in Yeast Lacking TOR1.Biochemical genetics · 2026Article
- Lifespan regulation by targeting heme signaling in yeast.GeroScience · 2024Article
- Lifespan regulation by targeting heme signaling in yeast.bioRxiv : the preprint server for biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Despite massive technological advances in mammalian models in recent years, studies in yeast still have the power to inform on the basic mechanisms of aging. Illustrating this, in Nan Hao's recent article published in the journal Science, he and his lab use microfluidics and fluorescent imaging technology to analyze the dynamics and interactions of aging mechanisms within yeast cells. They focused in on the Sir2 gene and the heme activator protein and, through the manipulation of these two molecular aging pathways, were able to determine that yeast cells can undergo one of three modes of aging, with one of them having a significantly longer lifespan than the others. These findings provide unexpected insights into mechanisms of aging, apparently as regulated fate-decision process, and open up avenues for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.